Giorgio Palù Selected Research

HIV Infections (HIV Infection)

8/2018	Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatment.
1/2014	HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up study.
7/2013	A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects.
2/2012	Baseline cellular HIV DNA load predicts HIV DNA decline and residual HIV plasma levels during effective antiretroviral therapy.
3/2011	KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giorgio Palù Research Topics

Disease

60	Infections 11/2021 - 07/2002
28	Neoplasms (Cancer) 08/2021 - 07/2002
15	Viremia 12/2018 - 09/2004
13	Tuberculosis (Tuberculoses) 01/2019 - 02/2007
10	Virus Diseases (Viral Diseases) 10/2018 - 09/2005
8	Human Influenza (Influenza) 01/2019 - 04/2012
8	Fibrosis (Cirrhosis) 08/2016 - 09/2005
7	Papillomavirus Infections 01/2019 - 07/2008
6	COVID-19 01/2022 - 01/2020
6	Inflammation (Inflammations) 08/2018 - 04/2005
5	HIV Infections (HIV Infection) 08/2018 - 03/2011
5	Liver Cirrhosis (Hepatic Cirrhosis) 04/2015 - 10/2008
4	Dengue (Dengue Fever) 01/2018 - 05/2014
4	Carcinoma (Carcinomatosis) 01/2018 - 01/2005
4	Carcinogenesis 10/2017 - 07/2006
4	Hepatitis C 02/2017 - 09/2007
4	Thyroid Neoplasms (Thyroid Cancer) 08/2004 - 11/2002
3	Pneumonia (Pneumonitis) 01/2022 - 07/2019
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 10/2005
3	Neoplasm Metastasis (Metastasis) 01/2019 - 07/2004
3	Communicable Diseases (Infectious Diseases) 10/2018 - 07/2013
3	West Nile Fever 03/2015 - 10/2013
3	Colitis 12/2013 - 04/2005
3	Hepatocellular Carcinoma (Hepatoma) 03/2006 - 05/2005
2	Persistent Infection 11/2021 - 09/2012
2	Neuroblastoma 01/2021 - 10/2003
2	Melanoma (Melanoma, Malignant) 01/2019 - 01/2013
2	Chronic Hepatitis C 01/2019 - 10/2009
2	Filoviridae Infections 04/2018 - 07/2015
2	Ebola Hemorrhagic Fever 04/2018 - 07/2015
2	Encephalitis (Encephalitis, Rasmussen) 01/2018 - 07/2015
2	Japanese Encephalitis 01/2018 - 05/2014
2	Fever (Fevers) 10/2017 - 10/2013
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 03/2017 - 12/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 12/2014
2	Coinfection 01/2017 - 08/2012
2	Ectrodactyly-cleft lip-palate syndrome 08/2016 - 01/2016
2	Cytomegalovirus Infections (Inclusion Disease) 01/2016 - 07/2008
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2015 - 12/2013
2	Disease Progression 04/2015 - 02/2012
2	Alcoholism (Alcohol Abuse) 09/2013 - 08/2010
2	Adenocarcinoma 06/2009 - 05/2005
2	Esophageal Achalasia (Megaesophagus) 07/2008 - 01/2004
2	Adrenocortical Carcinoma 02/2008 - 01/2005
2	Adrenocortical Adenoma (Disease, Conn's) 02/2008 - 01/2005
2	Wounds and Injuries (Trauma) 09/2007 - 04/2005

Drug/Important Bio-Agent (IBA)

24	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 07/2002
20	Antiviral Agents (Antivirals)IBA 01/2021 - 09/2005
17	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2004
16	Pharmaceutical PreparationsIBA 01/2022 - 10/2003
13	RNA (Ribonucleic Acid)IBA 01/2019 - 09/2004
11	VaccinesIBA 11/2021 - 09/2005
8	AntibodiesIBA 01/2020 - 05/2010
8	EnzymesIBA 01/2016 - 06/2009
8	CytokinesIBA 05/2010 - 11/2002
6	Interferon-gamma (Interferon, gamma)IBA 08/2013 - 01/2004
5	Viral RNAIBA 11/2021 - 04/2012
5	Viral DNAIBA 01/2021 - 11/2009
5	MicroRNAs (MicroRNA)IBA 01/2018 - 12/2014
4	Messenger RNA (mRNA)IBA 11/2021 - 07/2004
4	AntigensIBA 07/2014 - 07/2008
3	Oncogene Proteins (Oncogene Protein)IBA 08/2021 - 01/2018
3	Amiodarone (Amiodarona)FDA LinkGeneric 04/2018 - 07/2015
3	ImmunosorbentsIBA 01/2016 - 06/2012
3	Nucleic AcidsIBA 09/2015 - 01/2012
3	Papillomavirus Vaccines (HPV Vaccines)IBA 11/2014 - 12/2008
3	Interleukin-2 (IL2)IBA 01/2009 - 11/2002
3	Ganciclovir (Cytovene)FDA LinkGeneric 05/2005 - 11/2002
2	aloe emodinIBA 01/2021 - 10/2003
2	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2016
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 10/2003
2	Oseltamivir (Tamiflu)FDA Link 07/2019 - 01/2019
2	Monoclonal AntibodiesIBA 01/2019 - 01/2013
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2017
2	Cadherins (E-Cadherin)IBA 01/2019 - 04/2015
2	GTP Phosphohydrolases (GTPases)IBA 03/2017 - 12/2016
2	daclatasvirIBA 02/2017 - 08/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 04/2004
2	Ribavirin (Virazole)FDA LinkGeneric 08/2016 - 09/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2016 - 11/2012
2	Amino Acids FDA Link 03/2016 - 07/2008
2	Immunoglobulin G (IgG)IBA 01/2016 - 10/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2015 - 10/2008
2	Carbon Tetrachloride (Tetrachloromethane)IBA 04/2015 - 02/2011
2	Neuraminidase (Sialidase)IBA 10/2014 - 05/2014
2	Ion Channels (Ion Channel)IBA 10/2014 - 05/2014
2	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 05/2014 - 04/2012
2	gamma-Aminobutyric Acid (GABA)IBA 09/2012 - 08/2010
2	Indicators and Reagents (Reagents)IBA 06/2012 - 07/2002
2	Peroxidase (Myeloperoxidase)IBA 05/2010 - 04/2005
2	Virulence Factors (Pathogenicity Factors)IBA 05/2010 - 04/2007
2	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2009 - 01/2005
2	Estrogens (Estrogen)FDA Link 12/2009 - 02/2008
2	Thymidine KinaseIBA 01/2009 - 01/2003
2	Gonadal Steroid Hormones (Sex Hormones)IBA 02/2008 - 03/2005

Therapy/Procedure

23	Therapeutics 01/2021 - 07/2004
3	Immunotherapy 01/2019 - 08/2004
3	Transplantation 08/2010 - 09/2004
3	Highly Active Antiretroviral Therapy (HAART) 08/2006 - 03/2005
2	Radiotherapy 01/2019 - 07/2002